Cancer dormancy: isolation and characterization of dormant lymphoma cells.
- 1 March 1993
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (5) , 1829-1833
- https://doi.org/10.1073/pnas.90.5.1829
Abstract
"Tumor dormancy" is an operational term used to describe a prolonged quiescent state in which tumor cells are present, but tumor progression is not clinically apparent. Although clinical examples of tumor dormancy abound, little is known regarding the mechanisms underlying this state. Here we utilize an antibody-induced dormancy model of an aggressive murine B-cell lymphoma (BCL1) and show that the induction of the dormant state is accompanied by dramatic changes in tumor cell morphology and cell cycle status. These data indicate the feasibility of altering the malignant phenotype of transformed cells by specific signals originating at the cell surface, and they suggest new opportunities for therapeutic intervention in cancer.Keywords
This publication has 9 references indexed in Scilit:
- Cancer dormancy: studies of the murine BCL1 lymphoma.1991
- Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor CellsPublished by Elsevier ,1991
- Cancers after cyclosporine therapy.1988
- Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.The Journal of Immunology, 1987
- Emergence of Idiotype Variants during Treatment of B-Cell Lymphoma with Anti-Idiotype AntibodiesNew England Journal of Medicine, 1985
- Flow cytometric correlation between BrdU/Hoechst quench effect and base pair composition in mammalian cell nucleiHistochemistry and Cell Biology, 1985
- Immunotoxins: A New Approach to Cancer TherapyScience, 1983
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978
- Spontaneous murine B-cell leukaemiaNature, 1978